Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Importance of Accessory Protein Variants in the Pathogenicity of Sars-Cov-2 Publisher Pubmed



Hassan SS1 ; Choudhury PP2 ; Aljabali AAA4 ; Uhal BD5 ; Lundstrom K6 ; Rezaei N7, 32 ; Pizzol D8 ; Adadi P9 ; Lal A10 ; Soares A11 ; Mohamed Abd Elaziz T11, 12 ; Brufsky AM13 ; Azad GK14 ; Sherchan SP15 Show All Authors
Authors
  1. Hassan SS1
  2. Choudhury PP2
  3. Aljabali AAA4
  4. Uhal BD5
  5. Lundstrom K6
  6. Rezaei N7, 32
  7. Pizzol D8
  8. Adadi P9
  9. Lal A10
  10. Soares A11
  11. Mohamed Abd Elaziz T11, 12
  12. Brufsky AM13
  13. Azad GK14
  14. Sherchan SP15
  15. Baetasdacruz W16
  16. Takayama K17
  17. Serranoaroca A18
  18. Chauhan G19
  19. Palu G20
  20. Mishra YK21
  21. Barh D22, 23
  22. Santana Silva RJ24
  23. Andrade BS25
  24. Azevedo V23
  25. Goesneto A26
  26. Bazan NG27
  27. Redwan EM28
  28. Tambuwala M29
  29. Uversky VN30, 31
Show Affiliations
Authors Affiliations
  1. 1. Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram, 721140, India
  2. 2. Applied Statistics Unit, Indian Statistical Institute, Kolkata, 700108, West Bengal, India
  3. 3. Department of Chemistry, College of Art and Sciences, University of South Florida, Tampa, 33620, FL, United States
  4. 4. Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University-Faculty of Pharmacy, Irbid, 566, Jordan
  5. 5. Department of Physiology, Michigan State University, East Lansing, 48824, MI, United States
  6. 6. PanTherapeutics, Rte de Lavaux 49, Lutry, CH1095, Switzerland
  7. 7. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Italian Agency for Development Cooperation - Khartoum, Sudan Street 33, Al Amarat, Sudan
  9. 9. Department of Food Science, University of Otago, Dunedin, 9054, New Zealand
  10. 10. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States
  11. 11. Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, 78229-3900, TX, United States
  12. 12. Zoology Department, Faculty of Science, Minia University, El-Minia, 61519, Egypt
  13. 13. University of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, United States
  14. 14. Department of Zoology, Patna University, Patna, 800005, Bihar, India
  15. 15. Department of Environmental Health Sciences, Tulane University, New Orleans, 70112, LA, United States
  16. 16. Translational Laboratory in Molecular Physiology, Centre for Experimental Surgery, College of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
  17. 17. Center for iPS Cell Research and Application, Kyoto University, Japan
  18. 18. Biomaterial and Bioengineering Lab, Translational Research Centre San Alberto Magno, Catholic University of Valencia San Vicente M'artir, c/Guillem de Castro 94, Valencia, 46001, Spain
  19. 19. School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey, 64849, Nuevo Leon, Mexico
  20. 20. Department of Molecular Medicine, University of Padova, Via Gabelli 63, Padova, 35121, Italy
  21. 21. University of Southern Denmark, Mads Clausen Institute, NanoSYD, Alsion 2, Sonderborg, 6400, Denmark
  22. 22. Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purba Medinipur, WB, India
  23. 23. Departamento de Genetica, Ecologia e Evolucao, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
  24. 24. Departamento de Ciencias Biologicas (DCB), Programa de Pos-Graduacao em Genetica e Biologia Molecular (PPGGBM), Universidade Estadual de Santa Cruz (UESC), Rodovia Ilheus-Itabuna, km 16, Ilheus, 45662-900, BA, Brazil
  25. 25. Laboratorio de Bioinformatica e Quimica Computacional, Departamento de Ciencias Biologicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequie, 45206-190, Brazil
  26. 26. Laboratorio de Biologia Molecular e Computacional de Fungos, Departamento de Microbiologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
  27. 27. Neuroscience Center of Excellence, School of Medicine, LSU Health New Orleans, New Orleans, 70112, LA, United States
  28. 28. King Abdulaz University, Faculty of Science, Department of Biological Science, Saudi Arabia
  29. 29. School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, BT52 1SA, Northern Ireland, Ireland
  30. 30. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, 33612, FL, United States
  31. 31. Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Institutskiy pereulok, 9, Dolgoprudny, 141700, Moscow region, Russian Federation
  32. 32. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

Source: Archives of Biochemistry and Biophysics Published:2022


Abstract

The coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS- CoV-2) with an estimated fatality rate of less than 1%. The SARS-CoV-2 accessory proteins ORF3a, ORF6, ORF7a, ORF7b, ORF8, and ORF10 possess putative functions to manipulate host immune mechanisms. These involve interferons, which appear as a consensus function, immune signaling receptor NLRP3 (NLR family pyrin domain-containing 3) inflammasome, and inflammatory cytokines such as interleukin 1β (IL-1β) and are critical in COVID-19 pathology. Outspread variations of each of the six accessory proteins were observed across six continents of all complete SARS-CoV-2 proteomes based on the data reported before November 2020. A decreasing order of percentage of unique variations in the accessory proteins was determined as ORF3a > ORF8 > ORF7a > ORF6 > ORF10 > ORF7b across all continents. The highest and lowest unique variations of ORF3a were observed in South America and Oceania, respectively. These findings suggest that the wide variations in accessory proteins seem to affect the pathogenicity of SARS-CoV-2. © 2022 Elsevier Inc.
Other Related Docs
12. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
13. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
21. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)